Treatment Options for Adult Primary Liver Cancer
A link to a list of current clinical trials is included for each treatment section. For some types or stages of cancer, there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you.
Localized Resectable Adult Primary Liver Cancer
Call 1-800-4-CANCER For more information, U.S. residents may call the National Cancer Institute's (NCI's) Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 8:00 a.m. to 8:00 p.m., Eastern Time. A trained Cancer Information Specialist is available to answer your questions. Chat online The NCI's LiveHelp® online chat service provides Internet users with the ability to chat online with an Information Specialist. The...
Read the Get More Information From NCI article > >
Treatment of localizedresectable adult primaryliver cancer may include the following:
- Surgery (partial hepatectomy).
- Surgery (total hepatectomy) and livertransplant.
- A clinical trial of regional or systemic chemotherapy or biologic therapy following surgery.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with localized resectable adult primary liver cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.
Localized and Locally Advanced Unresectable Adult Primary Liver Cancer
Treatment of localized and locally advancedunresectable adult primaryliver cancer may include the following:
- Surgery (cryosurgery or radiofrequency ablation).
- Chemotherapy (chemoembolization, regional chemotherapy, or systemic chemotherapy).
- Percutaneous ethanol injection.
- Surgery (total hepatectomy) and liver transplant.
- Radiation therapy with radiosensitizers.
- A clinical trial of a combination of surgery, chemotherapy, and radiation therapy. Hyperthermia therapy may also be used. Chemotherapy and radiation therapy may be used to shrink the tumor before surgery.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with localized unresectable adult primary liver cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.
Advanced Adult Primary Liver Cancer
There is no standard treatment for advanced adult primaryliver cancer. Patients may consider taking part in a clinical trial. Treatment may be a clinical trial of biologic therapy, chemotherapy, and/or radiation therapy with or without radiosensitizers. These treatments may be given as palliative therapy to help relieve symptoms and improve the quality of life.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with advanced adult primary liver cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.
Recurrent Adult Primary Liver Cancer
Treatment of recurrent adult primaryliver cancer may include the following:
- Surgery (partial hepatectomy).
- Surgery (total hepatectomy) and livertransplant.
- Chemotherapy (chemoembolization or systemic chemotherapy).
- Percutaneous ethanol injection.
- A clinical trial of a new therapy.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with recurrent adult primary liver cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.
WebMD Public Information from the National Cancer Institute
